A brief in the Nov. 7, 2002, issue of BioWorld Today on AGY Therapeutics Inc., of South San Francisco, should have said the company discovered a gene involved in brain damage following stroke and also discovered genes that could lead to new therapies or diagnostic tests for Alzheimer's disease.

Editor's Note: The change has been made on BioWorld Online.